Skip to content
AnalystLens

CENTENE CORP 8-K Report, Executive Changes (Jun 22, 2026)

Reports
Leadership Changes·Regulation FD·Exhibits & Filings
Filing Date
Filed June 22, 2026
Period End
June 19, 2026
Security
CNC
In the record · 2016–202610-K1110-Q328-K217

CNC filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 217 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jul ’18Jul ’18
  2. Leadership change8-K · Jan ’20Jan ’20
  3. Deal closed8-K · Jan ’22Jan ’22
  4. Leadership change8-K · Aug ’25Aug ’25

Summary

Summary of the 8-K filed June 22, 2026. Cited figures are marked; the original filing is the authoritative source.

Centene Corporation (NYSE: CNC) filed an 8-K on June 22, 2026 to disclose that its Board of Directors, effective June 19, 2026, increased the Board's size from 9 to 10 members and elected Lauren M.

Tyler to fill the newly created seat, with a term expiring at the 2027 annual meeting of stockholders. Ms. Tyler is expected to join the Audit Committee and the Compensation and Talent Committee effective July 1, 2026, and will receive the standard non-employee director compensation as described in the company's March 27, 2026 proxy statement. Ms. Tyler brings a background largely from JPMorgan Chase & Co., where she spent over two decades, most recently as Executive Vice President and Global Head of Human Resources for the Asset & Wealth Management Division (2015-2024).

Earlier roles included Global Firmwide Chief Auditor (2014-2015) and Global Firmwide Head of Investor Relations (2009-2012). She currently sits on the boards of Cencora, Inc. and Guardian Life. The filing states there are no related-party transactions under Item 404(a), no family relationships with other directors or executives, and no arrangements under which she was selected as a director.

For investors, this is a routine governance event rather than a material financial disclosure. The filing contains no financial results, guidance, or changes to operations.

The appointment strengthens board expertise in audit, investor relations, and human capital, which is relevant given the company's oversight responsibilities in a heavily regulated, government-sponsored healthcare business. Investors may watch how her audit committee role develops, but the filing itself does not signal a change in strategy or financial outlook.

Key Highlights

  1. Board expanded from 9 to 10 members, effective June 19, 2026, with Lauren M. Tyler elected to fill the new seat
  2. Ms. Tyler's term runs until Centene's 2027 annual meeting of stockholders
  3. Tyler expected to join the Audit Committee and Compensation and Talent Committee effective July 1, 2026
  4. Tyler brings deep financial and governance experience, including 20+ years at JPMorgan Chase in roles spanning HR, chief audit, and investor relations
  5. Current board seats at Cencora, Inc. and Guardian Life; previously served on Alleghany Corporation's board until its 2022 acquisition
  6. Compensation follows the standard non-employee director program described in the March 27, 2026 proxy statement
  7. No related-party transactions, family relationships, or selection arrangements disclosed; filing contains no financial results or guidance

Frequently Asked Questions

  1. Why did Centene add a board member?

    The Board increased its size from 9 to 10 directors and elected Lauren M. Tyler to fill the resulting vacancy. The filing does not state a specific strategic reason beyond the press release's comments on her governance, talent development, and operational experience.

  2. What committees will Lauren Tyler serve on?

    She is anticipated to serve on the Audit Committee and the Compensation and Talent Committee, effective July 1, 2026.

  3. Does this appointment affect Centene's financial outlook?

    No. The 8-K and press release contain no financial results, guidance, or operational changes. It is a board governance update.

  4. How is Ms. Tyler compensated?

    She will participate in Centene's standard non-employee director compensation program, as described in the company's proxy statement filed March 27, 2026. The filing does not disclose specific compensation amounts.

  5. Are there any conflicts of interest or related-party concerns?

    The filing states there are no related-party transactions under Item 404(a) of Regulation S-K involving Ms. Tyler, no family relationships with any director or executive officer, and no arrangements or understandings under which she was elected.